Ingalls & Snyder LLC Organon & Co. Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $45,812 - $56,288	-1,447 Reduced 15.2%	8,073 $272,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $34,682 - $44,831	-1,139 Reduced 10.69%	9,520 $333,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $89,765 - $116,254	-3,131 Reduced 22.7%	10,659 $325,000
Q3 2021 Oct 27, 2021	SELL	$28.63 - $35.64 $480,067 - $597,611	-16,768 Reduced 54.87%	13,790 $452,000
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $869,375 - $1.16 Million	30,558 New	30,558 $925,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.